Personal profile
Research Biography
Dr Ross trained in clinical and laboratory haematology at the Royal Adelaide Hospital and Institute of Medical & Veterinary Science, spending one year at Addenbrooke's Hospital in Cambridge. In 2009 he was awarded a PhD for a thesis on the subject of minimal residual disease in chronic myeloid leukaemia.
In 2009 he joined the haematology department at Flinders Medical Centre, where he is responsible for diagnostic haematology services. He is an investigator in several clinical trials for haematological malignancies, and an active member of the Australasian Leukaemia & Lymphoma Group.
His areas of interest include myeloid malignancies and minimal residual disease.
Current projects include
- monitoring of treatment response in chronic myeloid leukaemia and acute promyelocytic leukaemia; and
- diagnosis of myeloproliferative neoplasms, such as polycythaemia rubra vera.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Prediction of relapse after discontinuation of tyrosine kinase inhibitor treatment in CML
Ross, D. M., 2026, In: Leukemia and Lymphoma. 67, 2, p. 243-245 3 p.Research output: Contribution to journal › Comment/debate
-
Ultraprecision therapy for type 1 vs type 2 CALR+MPN by dual epitope targeting that restores ruxolitinib sensitivity
Thompson-Peach, C. A. L., Thomas, D., Dottore, M., Lim, K., Stomski, F., Panagopoulos, R. A., Foßelteder, J., Reinisch, A., Chandrakanthan, V., Jenkner, S., Bland, L., Paton, S., Gronthos, S., Hercus, T. R., Wardill, H. R., Kan, W. L., Kamel, M. M., Moretti, P. A., Pitson, S. M. & Burbury, K. & 4 others, , 2 Apr 2026, In: Blood. 147, 14, p. 1611-1623 13 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey
Harrison, C. N., Ross, D. M., Fogliatto, L. M., Foltz, L., Busque, L., Xiao, Z., Heidel, F. H., Koehler, M., Palumbo, G. A., Breccia, M., Komatsu, N., Kirito, K., Xicoy Cirici, B., Martinez-Lopez, J., Rovo, A., Petruk, C., Bobirca, C., Mirams, L., McMillan, A. & Harper, G. & 1 others, , Mar 2025, In: HemaSphere. 9, 3, 10 p., e70106.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Citations (Scopus)61 Downloads (Pure) -
Response to venetoclax in patients with blastic plasmacytoid dendritic cell neoplasm
Sharplin, K. M., Vassiliou, C., Nguyen, J., Kuss, B. J., Ting, S. B., Mangos, H., Scott, H., Brown, A., Blombery, P., Wei, A. & Ross, D. M., May 2025, In: Leukemia Research. 152, 7 p., 107678.Research output: Contribution to journal › Letter › peer-review
-
The evolution of treatment-free remission
Hughes, T. P., Yong, A. S. M. & Ross, D. M., 27 Feb 2025, In: Blood. 145, 9, p. 921-930 10 p.Research output: Contribution to journal › Review article › peer-review
18 Citations (Scopus)
Projects
- 1 Active
-
A Comprehensive ADME Genomic Profile to Enhance Safety and Reduce Medicine Harms
Rowland, A. (Chief Investigator (Project Lead)), Westley, I. (Chief Investigator), Kichenadasse, G. (Chief Investigator), Sorich, M. (Chief Investigator), Newman, L. (Chief Investigator), Ross, D. (Chief Investigator), Branford, S. (Chief Investigator), Scott, H. (Chief Investigator), Hopkins, A. (Chief Investigator), Karapetis, C. (Chief Investigator), Guchelaar, H. J. (Chief Investigator), To, T. (Chief Investigator), Karnon, J. (Chief Investigator) & Haseloff, M. (Associate Investigator)
1/06/25 → 31/05/28
Project: Research